Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Status:
Terminated
Trial end date:
2014-02-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of CB-5945 for the treatment
of opioid-induced constipation (OIC)in adults taking opioid therapy for chronic non-cancer
pain.